Retrobulbar optic neuritis secondary to nivolumab therapy for metastatic melanoma in a 71-year-old patient affected by multiple sclerosis

Ital J Dermatol Venerol. 2022 Oct;157(5):454-455. doi: 10.23736/S2784-8671.22.07204-8.

Authors

Federica Marraffa¹, Agneszka Dybala¹, Sara Grassi², Federica Rega¹, Vincenzo Roberti¹, Andrea Vizzaccaro¹, Simone Michelini¹, Giovanni Pellacani¹, Antonio G Richetta¹

Affiliations

¹ Unit of Dermatology, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy.
² Unit of Dermatology, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy - sara.grassi03@gmail.com.

PMID: 36213972
DOI: 10.23736/S2784-8671.22.07204-8

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Humans
Melanoma* / drug therapy
Multiple Sclerosis* / drug therapy
Nivolumab / adverse effects
Optic Neuritis* / chemically induced

Substances

Nivolumab